Share:
Peer-Reviewed Publication
Hematol Oncol2026;44(5):e70231.September 1, 2026Journal Article

Nucleoporin 98 Rearrangements in Acute Leukemia: A Genomic Landscape Study.

Osama Batayneh1, Natalie Danziger2, Mahmoudreza Moein3, Nour S Naji3, Dean Pavlick2, Jeffrey S Ross2,4, Chelsea Marcus2, Caleb Ho2, Teresa Gentile1, Zheng Zhou5, Lincoln W Pasquina2
1Division of Hematology/Oncology, Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.
2Foundation Medicine, Inc., Boston, Massachusetts, USA.
3Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.
4Department of Pathology, SUNY Upstate Medical University, Syracuse, New York, USA.
5City of Hope, National Cancer Center, Duarte, California, USA.

Abstract

Nucleoporin 98 rearrangements (NUP98re) occur in a wide range of hematologic malignancies including acute leukemias with a variety of fusion partners. NUP98re is associated with adverse prognosis, especially in children. We aimed to better understand the genomics of acute leukemias with NUP98re including fusion partners and co-occurring genomic alterations (GA). Results from 5905 patients with acu…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.